Kingsview Wealth Management LLC boosted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 230.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 11,676 shares of the financial services provider's stock after acquiring an additional 8,147 shares during the period. Kingsview Wealth Management LLC's holdings in CME Group were worth $2,711,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Truvestments Capital LLC bought a new stake in shares of CME Group during the 3rd quarter valued at $26,000. SJS Investment Consulting Inc. grew its holdings in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock valued at $26,000 after buying an additional 97 shares in the last quarter. Dunhill Financial LLC lifted its holdings in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider's stock worth $27,000 after buying an additional 81 shares in the last quarter. Financial Life Planners bought a new position in shares of CME Group in the fourth quarter valued at approximately $32,000. Finally, Fortitude Family Office LLC grew its stake in CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock valued at $35,000 after acquiring an additional 83 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
NASDAQ:CME opened at $244.83 on Monday. The company has a 50-day moving average price of $235.48 and a 200-day moving average price of $224.13. The stock has a market cap of $88.23 billion, a price-to-earnings ratio of 25.74, a P/E/G ratio of 5.54 and a beta of 0.57. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02.
CME Group declared that its board has approved a share buyback plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its stock is undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 2.04%. This is a boost from CME Group's previous quarterly dividend of $1.15. The ex-dividend date is Friday, March 7th. CME Group's payout ratio is presently 48.37%.
A number of research analysts have recently commented on the stock. Keefe, Bruyette & Woods reduced their price target on shares of CME Group from $260.00 to $256.00 and set a "market perform" rating for the company in a research report on Monday, January 13th. Piper Sandler upped their target price on CME Group from $250.00 to $258.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 7th. Oppenheimer lifted their price target on CME Group from $245.00 to $258.00 and gave the company an "outperform" rating in a research report on Thursday, October 24th. Royal Bank of Canada restated a "sector perform" rating and issued a $235.00 price objective on shares of CME Group in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of CME Group from $227.00 to $226.00 and set a "hold" rating for the company in a research report on Monday, November 11th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $229.27.
View Our Latest Report on CME
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.